Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 1501-1512 of 1905 results.
"To improve outcomes, nurses should adhere to evidence-based protocols for maintaining IV patency and proactively educate mothers on recognizing signs of phlebitis" Casman et al (2025).
"The heparin-vancomycin-amikacin combination lock solution was more effective in preventing CRIs than heparin alone in haemodialysis patients” Arabzadeh et al (2025).
"Length of stay increased by an average of 5.2 days for falls, 12.9 days for pressure ulcers, 22.1 days for central line-associated bloodstream infections, and 7.9 days for surgical site infections” Hasan et al (2025).
"Evidence on the safety and cost-effectiveness of IV anti-cancer therapy at home is scarce and outdated. IV anti-cancer regimens have evolved; the findings of studies performed more than a decade ago may lack applicability to current practice. However, key considerations when considering suitability for home treatment remain unchanged: safety, duration of treatment and geographic catchment area” Grobler et al (2025).
"Nursing staff from a healthcare company in Rome, Italy, participated in a 25-h Field Training Course, focusing on vascular access management, promoting collaborative learning, reflection and research. Participants filled in the Nurses' knowledge and self-efficacy on vascular access devices questionnaire pre and post-course” Lommi et al (2025).
"This case report discusses a patient who presented with symptoms of a misplaced dialysis catheter and developed a life-threatening tension haemopneumothorax during its removal, in association with prior haemothorax” Patel et al (2025).
"To investigate the risk factors for complications in breast cancer patients with totally implantable access ports (TIAPs)” Fan et al (2025).
"This study aims to evaluate the satisfaction and health-related quality of life (HRQoL) in cancer patients with chest ports and to understand their experiences and challenges” Nie et al (2025).
"Infusion port catheter malposition, where the catheter tip is located in vessels other than the superior vena cava, is a rare complication of port implantation. This can lead to infusion difficulties or port-related thrombosis” Guo et al (2025).
"A 50-year-old lady receiving venous port implantation for chemotherapy was found with a catheter disconnected from the port and dislodged into the right ventricle” Guo et al (2025).
"To compare the safety and efficacy of the Internal Jugular Vein and the Axillary Vein access points for port-a-cath implantation in cancer patients undergoing systemic intravenous treatments” Pignataro et al (2025).
"This review provides ED clinicians with current evidence on VAD technologies and techniques, enabling them to select and implement the most effective options into daily practice reduce costs and improve patient satisfaction" Xu et al (2025).
